SMS PHARMACEUTICALS LTD. Intrinsic Value

SMSPHARMA · Healthcare · Current price ₹368.45

Full stock page
DocStoX fair value
₹238
low confidence
Current price
₹368
Upside to fair value
-35.5%
Verdict
Avoid
Quality score
4.5 / 10
Model it yourself — Intrinsic Value Calculator
Opens pre-filled with SMS PHARMACEUTICALS LTD.'s latest numbers.

Is SMS PHARMACEUTICALS LTD. undervalued?

DocStoX estimates the fair value of SMS PHARMACEUTICALS LTD. at ₹238 per share, versus the current market price of ₹368. That puts the stock about -35.5% above our fair-value estimate, which we read as "Avoid". Our confidence in this estimate is low.

How this fair value is calculated

This estimate blends 4 independent methods: Residual income (₹86), Relative P/E (₹418), Graham floor (₹143), Analyst target (₹464). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.

Bear, base and bull scenarios

Our scenarios span ₹86 (bear) to ₹238 (base) to ₹464 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.

Margin of safety

Value investors demand a margin of safety — a discount to intrinsic value that protects against being wrong. At ₹368 versus an intrinsic value of ₹238, SMS PHARMACEUTICALS LTD. currently offers -35.5% of negative margin (i.e. a premium).

More on SMS PHARMACEUTICALS LTD.

Fair ValueDCFValuationFinancial RatiosPeers

DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.